Cory David A 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-03-12+230,000→ 230,000 totalExercise: $5.60Exp: 2030-03-11→ Common Stock (230,000 underlying) - Award
Common Stock
2020-03-05$7.31/sh+1,500$10,965→ 69,346 total
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The option vests in equal monthly installments over 48 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date.